Patents by Inventor Siok Ping Yeo

Siok Ping Yeo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IL-1? neutralizing human monoclonal antibodies
    Patent number: 11912761
    Abstract: The present invention is directed to antigen binding proteins and in particular to IL-1? antigen binding proteins. The present invention further provides compositions comprising the antigen binding proteins, use of the antigen binding proteins and methods for production.
    Type: Grant
    Filed: January 15, 2021
    Date of Patent: February 27, 2024
    Assignee: Agency for Science, Technology and Research
    Inventors: Cheng-I Wang, Angeline Goh, Siok Ping Yeo, Alessandra Rosa Mortellaro, Subhra Kumar Biswas, Florent Ginhoux, Pingyu Zhong
  • IL2RBETA/COMMON GAMMA CHAIN ANTIBODIES
    Publication number: 20240052046
    Abstract: Antigen binding molecules capable of binding to CDI22 and/or common y? chain (CDI32) are disclosed herein. Also disclosed are compositions comprising such antigen binding molecules, and uses and methods using the same.
    Type: Application
    Filed: June 29, 2023
    Publication date: February 15, 2024
    Applicants: Agency for Science, Technology and Research, Euchloe Bio Pte. Ltd.
    Inventors: Peter Brauer, John Edward Connolly, Richard Hopkins, Junyun Lai, Jianrong Lionel Low, Kar Wai Tan, Cheng-I Wang, Siok Ping Yeo
  • IL-1? neutralizing human monoclonal antibodies
    Patent number: 11780913
    Abstract: The present invention is directed to antigen binding proteins and in particular to IL-1? antigen binding proteins. The present invention further provides compositions comprising the antigen binding proteins, use of the antigen binding proteins and methods for production.
    Type: Grant
    Filed: October 1, 2020
    Date of Patent: October 10, 2023
    Assignee: Agency for Science, Technology and Research
    Inventors: Cheng-I Wang, Angeline Goh, Siok Ping Yeo, Alessandra Rosa Mortellaro, Subhra Kumar Biswas, Florent Ginhoux, Pingyu Zhong
  • IL2Rbeta/common gamma chain antibodies
    Patent number: 11739157
    Abstract: Antigen binding molecules capable of binding to CD122 and/or common ? chain (CD132) are disclosed herein. Also disclosed are compositions comprising such antigen binding molecules, and uses and methods using the same.
    Type: Grant
    Filed: November 9, 2018
    Date of Patent: August 29, 2023
    Assignees: Agency for Science, Technology and Research, Euchloe Bio Pte. Ltd.
    Inventors: Peter Brauer, John Edward Connolly, Richard Hopkins, Junyun Lai, Jianrong Lionel Low, Kar Wai Tan, Cheng-l Wang, Siok Ping Yeo
  • IL-1? neutralizing human monoclonal antibodies
    Patent number: 11702471
    Abstract: The present invention is directed to antigen binding proteins and in particular to IL-1? antigen binding proteins. The present invention further provides compositions comprising the antigen binding proteins, use of the antigen binding proteins and methods for production.
    Type: Grant
    Filed: January 15, 2021
    Date of Patent: July 18, 2023
    Assignee: Agency for Science, Technology and Research
    Inventors: Cheng-I Wang, Angeline Goh, Siok Ping Yeo, Alessandra Rosa Mortellaro, Subhra Kumar Biswas, Florent Ginhoux, Pingyu Zhong
  • ANTI-PD-L1 ANTIBODIES
    Publication number: 20230201345
    Abstract: Anti-PD-L1 antibodies are disclosed. Also disclosed are pharmaceutical compositions comprising such antibodies, and uses and methods using the same.
    Type: Application
    Filed: November 23, 2022
    Publication date: June 29, 2023
    Applicant: Agency for Science, Technology and Research
    Inventors: Cheng-I Wang, Hsueh Ling Janice Oh, Siok Ping Yeo
  • Anti-PD-L1 antibodies
    Patent number: 11534489
    Abstract: Anti-PD-L1 antibodies are disclosed. Also disclosed are pharmaceutical compositions comprising such antibodies, and uses and methods using the same.
    Type: Grant
    Filed: October 9, 2019
    Date of Patent: December 27, 2022
    Assignee: Agency for Science, Technology and Research
    Inventors: Cheng-i Wang, Hsueh Ling Janice Oh, Siok Ping Yeo
  • IL2RBETA/COMMON GAMMA CHAIN ANTIBODIES
    Publication number: 20220251221
    Abstract: Antigen binding molecules capable of binding to CD122 and/or common ? chain (CD132) are disclosed herein. Also disclosed are compositions comprising such antigen binding molecules, and uses and methods using the same.
    Type: Application
    Filed: November 9, 2018
    Publication date: August 11, 2022
    Applicants: Agency for Science, Technology and Research, Euchloe Bio Pte. Ltd.
    Inventors: Peter Brauer, John Edward Connolly, Richard Hopkins, Junyun Lai, Jianrong Lionel Low, Kar Wai Tan, Cheng-l Wang, Siok Ping Yeo
  • Anti-CTLA-4 antibodies
    Patent number: 11267887
    Abstract: Anti-CTLA-4 antibodies are disclosed. Also disclosed are compositions comprising such antibodies, and uses and methods using the same.
    Type: Grant
    Filed: April 13, 2017
    Date of Patent: March 8, 2022
    Assignee: Agency for Science, Technology and Research
    Inventors: Cheng-I Wang, Eve Ngoh, Siok Ping Yeo
  • Anti-TIM-3 antibodies
    Patent number: 11142574
    Abstract: Anti-TIM-3 antibodies are disclosed. Also disclosed are pharmaceutical compositions comprising such antibodies, and uses and methods using the same.
    Type: Grant
    Filed: March 6, 2019
    Date of Patent: October 12, 2021
    Assignee: Agency for Science, Technology and Research
    Inventors: Cheng-I Wang, Hsueh Ling Janice Oh, Siok Ping Yeo, Yun Pei Sharon Goh
  • Anti-PD-1 antibodies
    Patent number: 11072659
    Abstract: Anti-PD-1 antibodies are disclosed. Also disclosed are pharmaceutical compositions comprising such antibodies, and uses and methods using the same.
    Type: Grant
    Filed: March 21, 2019
    Date of Patent: July 27, 2021
    Assignee: Agency for Science, Technology and Research
    Inventors: Cheng-I Wang, Hsueh Ling Janice Oh, Siok Ping Yeo, Jianrong Lionel Low, Hwee Ching Tan
  • IL-1Beta Neutralizing Human Monoclonal Antibodies
    Publication number: 20210155685
    Abstract: The present invention is directed to antigen binding proteins and in particular to IL-1? antigen binding proteins. The present invention further provides compositions comprising the antigen binding proteins, use of the antigen binding proteins and methods for production.
    Type: Application
    Filed: January 15, 2021
    Publication date: May 27, 2021
    Applicant: Agency for Science, Technology and Research
    Inventors: Cheng-I WANG, Angeline GOH, Siok Ping YEO, Alessandra Rosa MORTELLARO, Subhra Kumar BISWAS, Florent GINHOUX, Pingyu ZHONG
  • IL-1Beta Neutralizing Human Monoclonal Antibodies
    Publication number: 20210155686
    Abstract: The present invention is directed to antigen binding proteins and in particular to IL-1? antigen binding proteins. The present invention further provides compositions comprising the antigen binding proteins, use of the antigen binding proteins and methods for production.
    Type: Application
    Filed: January 15, 2021
    Publication date: May 27, 2021
    Applicant: Agency for Science, Technology and Research
    Inventors: Cheng-I WANG, Angeline GOH, Siok Ping YEO, Alessandra Rosa MORTELLARO, Subhra Kumar BISWAS, Florent GINHOUX, Pingyu ZHONG
  • Method of reducing tumor growth with IL-1beta neutralizing human monoclonal antibodies
    Patent number: 10919962
    Abstract: The present invention is directed to antigen binding proteins and in particular to IL-1? antigen binding proteins. The present invention further provides compositions comprising the antigen binding proteins, use of the antigen binding proteins and methods for production.
    Type: Grant
    Filed: November 15, 2018
    Date of Patent: February 16, 2021
    Assignee: Agency for Science, Technology and Research
    Inventors: Cheng-I Wang, Angeline Goh, Siok Ping Yeo, Alessandra Rosa Mortellaro, Subhra Kumar Biswas, Florent Ginhoux, Pingyu Zhong
  • IL-1BETA NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES
    Publication number: 20210024627
    Abstract: The present invention is directed to antigen binding proteins and in particular to IL-1? antigen binding proteins. The present invention further provides compositions comprising the antigen binding proteins, use of the antigen binding proteins and methods for production.
    Type: Application
    Filed: October 1, 2020
    Publication date: January 28, 2021
    Applicant: Agency for Science, Technology and Research
    Inventors: Cheng-I WANG, Angeline GOH, Siok Ping YEO, Alessandra Rosa MORTELLARO, Subhra Kumar BISWAS, Florent GINHOUX, Pingyu ZHONG
  • IL2R common gamma chain antibodies
    Patent number: 10696747
    Abstract: Anti-CD122 and/or ?c antibodies and fragments thereof are disclosed. Also disclosed are compositions comprising such antibodies and fragments, and uses and methods using the same.
    Type: Grant
    Filed: August 24, 2018
    Date of Patent: June 30, 2020
    Assignee: Agency for Science, Technology and Research
    Inventors: Cheng-I Wang, Peter Brauer, Siok Ping Yeo, Hwee Ching Tan, John Edward Connolly
  • Anti-PD-L1 Antibodies
    Publication number: 20200093922
    Abstract: Anti-PD-L1 antibodies are disclosed. Also disclosed are pharmaceutical compositions comprising such antibodies, and uses and methods using the same.
    Type: Application
    Filed: October 9, 2019
    Publication date: March 26, 2020
    Inventors: Cheng-i WANG, Hsueh Ling Janice OH, Siok Ping YEO
  • Anti-TIM-3 Antibodies
    Publication number: 20200055935
    Abstract: Anti-TIM-3 antibodies are disclosed. Also disclosed are pharmaceutical compositions comprising such antibodies, and uses and methods using the same.
    Type: Application
    Filed: August 27, 2019
    Publication date: February 20, 2020
    Inventors: Cheng-I WANG, Hsueh Ling Janice OH, Siok Ping YEO, Yun Pei Sharon GOH
  • Anti-PD-L1 antibodies
    Patent number: 10517949
    Abstract: Anti-PD-L1 antibodies are disclosed. Also disclosed are pharmaceutical compositions comprising such antibodies, and methods of using such antibodies to restore T-cell function in T-cells exhibiting T-cell exhaustion or T-cell anergy.
    Type: Grant
    Filed: January 4, 2016
    Date of Patent: December 31, 2019
    Assignee: Agency for Science, Technology and Research
    Inventors: Cheng-i Wang, Hsueh Ling Janice Oh, Siok Ping Yeo
  • Method for expansion of a population of cells with IL2R beta/common gamma chain antibodies
    Patent number: 10472421
    Abstract: Anti-CD122 and/or ?c antibodies and fragments thereof are disclosed. Also disclosed are compositions comprising such antibodies and fragments, and uses and methods using the same.
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: November 12, 2019
    Assignee: Agency for Science, Technology and Research
    Inventors: Cheng-I Wang, Peter Brauer, Siok Ping Yeo, Hwee Ching Tan, John Edward Connolly